Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer. Wugen is leveraging its proprietary Moneta platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat hematological and solid tumor malignancies.
Wugen is based out of St. Louis, Missouri and San Diego, California.
Industry
Biotechnology Research, Scientific Research and Development Services, Services
HQ Location
4260 Forest Park Ave
Suite 100
St. Louis, Missouri 63108, US
Keywords
bone marrow transplantbiomedical engineeringmedical sciencesoncology drugactive biotechfinancial servicesoncology clinical trialsmanufacturing celltherapeutic antibodiesmolecular microbiology